These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1300272)

  • 1. [Therapeutic effect of lymphocytapheresis on patients with HTLV-I-associated myelopathy (HAM)].
    Kubota R; Nakagawa M; Nakamura A; Osame M
    Rinsho Shinkeigaku; 1992 Sep; 32(9):984-8. PubMed ID: 1300272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased.
    Al-Fahim A; Cabre P; Kastrukoff L; Dorovini-Zis K; Oger J
    Cell Immunol; 1999 Nov; 198(1):1-10. PubMed ID: 10612646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of pulmonary involvement in HTLV-I-associated myelopathy (HAM): studies on T-cell function].
    Sugimoto M; Matsumoto M; Nakashima H; Imamura F; Kawano O; Imamura S; Fukuda Y; Ando M; Araki S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Oct; 27(10):1198-203. PubMed ID: 2615072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
    J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.
    Eiraku N; Hingorani R; Ijichi S; Machigashira K; Gregersen PK; Monteiro J; Usuku K; Yashiki S; Sonoda S; Osame M; Hall WW
    J Immunol; 1998 Dec; 161(12):6674-80. PubMed ID: 9862696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy.
    Furuya T; Nakamura T; Shirabe S; Nishiura Y; Tsujino A; Goto H; Nakane S; Eguchi K; Nakamura H; Nagataki S
    Proc Assoc Am Physicians; 1997 May; 109(3):228-36. PubMed ID: 9154639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
    Azimi N; Jacobson S; Leist T; Waldmann TA
    J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1.
    Pinheiro SR; Martins-Filho OA; Ribas JG; Catalan-Soares BC; Proietti FA; Namen-Lopes S; Brito-Melo GE; Carneiro-Proietti AB;
    Am J Ophthalmol; 2006 Nov; 142(5):811-15. PubMed ID: 16989761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
    Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
    J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
    Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and immunovirology of human T-cell leukemia/lymphoma virus type I-associated adult T-cell leukemia and chronic myelopathies as seen in France.
    Gessain A; Gout O; Saal F; Daniel MT; Rio B; Flandrin G; Sigaux F; Lyon-Caen O; Periès J; de-Thé G
    Cancer Res; 1990 Sep; 50(17 Suppl):5692S-5696S. PubMed ID: 2201441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
    Lehky TJ; Levin MC; Kubota R; Bamford RN; Flerlage AN; Soldan SS; Leist TP; Xavier A; White JD; Brown M; Fleisher TA; Top LE; Light S; McFarland HF; Waldmann TA; Jacobson S
    Ann Neurol; 1998 Dec; 44(6):942-7. PubMed ID: 9851439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bronchopneumonopathy in HTLV-1 associated myelopathy (HAM) and non-HAM HTLV-1 carriers].
    Maruyama I; Mori S; Kawabata M; Osame M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):775-9. PubMed ID: 1630040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T-lymphocytosis and increased levels of soluble IL-2 receptors in bronchoalveolar lavage fluid in cases of HTLV-I-associated myelopathy with pulmonary involvement].
    Sugimoto M; Nakashima H; Matsumoto M; Kawano O; Imamura F; Ando M; Araki S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):481-7. PubMed ID: 2796057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells.
    Cavrois M; Gessain A; Gout O; Wain-Hobson S; Wattel E
    J Infect Dis; 2000 Oct; 182(4):1044-50. PubMed ID: 10979898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of leukocytapheresis and low-dose prednisolone treatment in a patient with HTLV-I-associated myelopathy (HAM)].
    Ijichi S; Ijichi N; Osame M; Izumihara T; Niimura T
    Rinsho Shinkeigaku; 1990 May; 30(5):544-7. PubMed ID: 2401115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.